Enforcement at the Speed of Light: DOJ Issues New Memo Mandating Accelerated Review of Benefits Fraud Qui Tam Cases

On May 27, 2026, Assistant Attorney General Brett A. Shumate of the Department of Justice’s Civil Division announced his issuance of a memorandum titled “Accelerating Review and Enhancing Enforcement in Benefits Fraud Matters,” which was issued in connection with the president’s March 16, 2026 Executive Order titled “Establishing the Task Force to Eliminate Fraud.” The memorandum (the “Shumate Memo”) directs DOJ attorneys and Assistant U.S. Attorneys handling False Claims Act (“FCA”) cases to dramatically compress the timeline for investigating and making intervention decisions in qui tam actions alleging fraud against federally funded, state-administered benefits programs (“benefits fraud” cases). Below, we summarize the key provisions of the Shumate Memo and provide our analysis of the practical implications for companies that participate in the kinds of benefits programs that are likely covered by this new effort, such as Medicaid, the Supplemental Nutrition Assistance Program (SNAP), Community Development Block Grants, and Temporary Assistance for Needy Families (TANF), among others.

Summary of the Shumate Memo

The Shumate Memo reflects the administration’s continued prioritization of FCA enforcement, which produced record-breaking recoveries exceeding $6.8 billion in fiscal year 2025, the highest amount in a single year. Assistant Attorney General Shumate frames the new directive as a response to the “rise in fraudulent schemes” targeting federal benefits programs, including healthcare programs such as Medicaid.

Compressed Investigation and Intervention Timelines

The most consequential provision of the Shumate Memo establishes aggressive new timelines for the government’s review of qui tam actions concerning benefits fraud. Under existing law, the government has an initial 60-day seal period to review a qui tam complaint and decide whether to intervene, with extensions available for “good cause.” 31 U.S.C. § 3730(b)(2)-(3). In practice, however, most intervened or settled cases remain under seal for much longer (often exceeding two years), with periodic extensions granted by federal district court judges, often in six-month increments.

The Shumate Memo now instructs that within 90 days of a new benefits fraud qui tam filing (the “Investigative Period”), DOJ attorneys should assess the case for an election decision—that is, whether the government will intervene or decline. If further time is needed to complete the investigation, approval must be sought and obtained not only from the courts but also within DOJ. An additional 120 days to complete an investigation must first be sought from the Deputy Assistant Attorney General of the Commercial Litigation Branch—currently Brenna E. Jenny—and any subsequent extension of the Investigative Period beyond that point will require approval from the Assistant Attorney General of the Civil Division, Shumate himself.

New Referral and Coordination Requirements

The Shumate Memo also describes a “whole-of-government” approach to new benefits fraud matters, though this coordination mostly occurs already under existing protocols. Under this framework:

• New matters will be promptly referred to the Criminal Division and/or the National Fraud Enforcement Division (“NFED”) for evaluation of potential criminal violations.
• New matters will be shared with the affected federal agency to evaluate potential administrative action, including payment suspension.
• DOJ will seek information from the affected agency regarding the operation of the impacted program, data analysis, and other information to corroborate the whistleblower’s allegations.

Key Takeaways

The Scope of Affected Cases Is Somewhat Unclear

The Shumate Memo is addressed specifically to “benefits fraud matters,” not to FCA enforcement generally. This could present an important limitation. The FCA covers a broad range of fraud—from Medicare and customs-related fraud to fraud in government contracting and cybersecurity—and the Shumate Memo does not purport to apply to all of these areas. At the same time, the term “benefits fraud” is not precisely defined, and it remains to be seen how expansively DOJ will interpret its scope. Companies participating in the Medicaid program and other federally funded benefit programs are the most obvious targets, but the boundaries may extend further. Companies should monitor DOJ guidance and enforcement actions to understand the scope of these changes as they roll out.

The 90-to-120-Day Election Decision Timeline May be Challenging in Practice

The Shumate Memo’s 90-day initial target for an election decision represents a radical departure from historical practice. The FCA provides a statutory 60-day seal period, but DOJ has long recognized that this period is “simply insufficient” for most cases.¹ Extensions for “good cause” are routinely granted under 31 U.S.C. § 3730(b)(3), and in practice, DOJ investigations commonly take years. Indeed, it can take more than 60 days from the time a qui tam complaint is filed simply for the complaint to be properly routed within DOJ and for DOJ to assemble an investigative team, before any substantive investigation has begun.

The complexity of benefits fraud cases makes these compressed timelines even more challenging. For example, healthcare fraud investigations routinely require DOJ attorneys to navigate intricate state Medicaid regulations, analyze voluminous claims data, consult with program-integrity officials and CMS subject matter experts, and engage medical and statistical experts. Completing these steps within 90 to 120 days in most cases, not to mention engaging with the investigation’s target and third parties to obtain additional (often highly relevant) information, is very unlikely. The Shumate Memo may ultimately create pressure for rushed election decisions or, alternatively, a flood of extension requests to DAAG Jenny and AAG Shumate.

The Extension Approval Process Adds Another Layer of Bureaucracy

The Shumate Memo’s extension protocol itself will consume significant attorney time. Any extension beyond the initial 90-day Investigative Period requires the preparation and submission of a written request to DAAG Jenny for approval of up to 120 additional days. Extensions beyond that 120-day window must go to AAG Shumate. These memoranda will themselves require considerable time to draft, review, and process—an administrative burden that may paradoxically slow the investigations the Shumate Memo seeks to accelerate.

Increased Declinations and Reliance on Relators

One potential consequence of the compressed timelines is a significant increase in declinations. Currently, fewer than 25% of filed qui tam actions result in government intervention, for either the purpose of settlement or litigation. If DOJ cannot complete its investigation within the prescribed windows, intervention may occur in even fewer cases, as the government may decline cases that historically would have merited intervention simply because DOJ’s self-imposed clock has run out.

The result is that DOJ increasingly would be relying on relators to litigate benefits fraud matters. That strategy could be complicated if an adverse ruling is issued in United States ex rel. Zafirov v. Florida Medical Associates, LLC, currently pending before the Eleventh Circuit. In that case, the district court held for the first time that the FCA’s qui tam provisions are unconstitutional under the Appointments Clause of Article II, reasoning that relators exercise “significant authority” on behalf of the United States without proper appointment. Although AAG Shumate’s announcement foreshadows the government’s “ongoing supervision and ultimate control of” relator-litigated benefit fraud cases, if the Eleventh Circuit upholds the district court’s ruling—or if the Supreme Court ultimately curtails the qui tam mechanism—DOJ’s strategy of relying on relators to pursue benefits fraud matters that it has declined may become unworkable.

Questions Remain Regarding Coordination with the Newly Established National Fraud Enforcement Division

The Shumate Memo directs that new benefits fraud matters be promptly referred to the NFED for evaluation of potential criminal violations. The NFED was formally established by Acting Attorney General Todd Blanche on April 7, 2026, and is led by Assistant Attorney General Colin McDonald. Many of the referral pathways contemplated in the Shumate Memo—referrals to the Criminal Division, coordination with affected agencies, sharing information for administrative action—already occur in the ordinary course of FCA enforcement. What is new is the addition of the NFED as a referral destination, and the expectation that this will happen systematically for all benefits fraud matters.

The NFED is intended to consolidate fraud enforcement resources under a single leadership structure, establish a National Fraud Detection Center, and rapidly expand prosecutorial capacity nationwide. But the Division is less than two months old, and to date, its primary efforts have been focused on criminal matters, with its staff comprised of criminal prosecutors. It is not yet clear how DOJ’s efforts to combat fraud through civil litigation will overlap with the work of the NFED.

Compressed Investigation Timelines Will Likely Present Challenges for Entities Under Investigation

In addition to focusing on the intervention timeline, the Shumate Memo also sets forth specific recommendations for fast-tracking investigations. Several of these have implications for entities under investigation. For example, the Shumate Memo encourages DOJ attorneys to set firm deadlines for defendants to respond to civil investigative demands (“CIDs”). If defendants fail to meet these deadlines, the Shumate Memo encourages DOJ to bring an action to enforce the CID. Additionally, the Shumate Memo suggests that early witness interviews and oral examinations should be considered as alternatives to document productions. These shorter response deadlines could place additional pressure on entities under investigation. Companies that participate in federal benefits programs should be prepared to respond to CIDs on an expedited basis. The heightened pace of enforcement underscores the importance of proactive compliance monitoring and early engagement of counsel when issues arise.

Conclusion

The Shumate Memo signals the administration’s intent to dramatically accelerate the pace of FCA enforcement in the benefits fraud space (and, by doing so, encourage relators and their counsel to file qui tam actions alleging benefits fraud in even greater numbers). While the stated objectives—faster resolution of qui tam matters, better interagency coordination, and more efficient use of DOJ resources—may be appealing to DOJ in principle, the practical challenges are significant. Companies that participate in federal benefits programs should take the Shumate Memo seriously as an indicator of heightened enforcement activity, even as significant questions remain about whether the compressed timelines can be operationalized in practice.